Glaxo Profits Reflect Strong Sterling

Stock quotes in this article: GSK  

The company's vaccine business posted a 6% sales gain to $721 million; the Coreg family of drugs for high blood pressure and chronic heart failure advanced 8% to $425 million; and the Avandia family of diabetes drugs gained 19% to $811 million.

Popular drugs whose sales were hammered due to generic competition in the U.S. included the antidepressant Wellbutrin XL, sales of which fell 37%; the antihistamine Flonase, which dropped 49%; and Zofran, the anti-nausea drug for patients receiving chemotherapy, which fell 60%.

GlaxoSmithKline's stock was down 5 cents to $58.76 in recent afternoon trading.

  • Loading Comments...
  •  
1 2
Next >

SHARE:

  • email
  • print
  • comment
  • digg
  • delicious
  • linkedin




Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,270.47 1,093.48 2,167.88 34.29
Oil *
75.55
UP
73.00
UP
6.24
UP
18.86
DOWN
0.17
10 Yr
3.43%
SPDR Gold
109.74
+0.72%
+0.57%
+0.88%
-0.49%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services